J. Navarro-Pérez

发表

Renal function and attributable risk of death and cardiovascular hospitalization in patients with cardiovascular risk factors from a registry-based cohort: the Estudio Cardiovascular Valencia-risk study

S. Pita-Fernández, J. Redón, J. Martin-Moreno, 2016, Journal of hypertension.

Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study

R. Cooper, S. Pita-Fernández, J. Redón, 2017, PloS one.

Renal function and attributable risk of death and cardiovascular hospitalization in participants with diabetes from a registry-based cohort.

J. Redón, J. Martin-Moreno, M. Tellez-Plaza, 2020, Primary care diabetes.

GLP-1 Receptor Agonists and Diabetic Kidney Disease: A Call of Attention to Nephrologists

B. Fernández-Fernández, A. Ortiz, J. Górriz, 2020, Journal of clinical medicine.

Epidemiology of Herpes Zoster Infection among Patients Treated in Primary Care Centres in the Valencian Community (Spain)

J. Díez-Domingo, J. Puig-Barberá, J. Navarro-Pérez, 2010, BMC family practice.

[Bibliometric analysis of International Scientific production on primary care].

J. Basora, M. Carratalá-Munuera, D. Orozco-Beltrán, 2012, Atencion primaria.

Predictive validity of the risk SCORE model in a Mediterranean population with dyslipidemia.

C. Brotons, J. A. Quesada, A. López-Pineda, 2019, Atherosclerosis.

Characterizing Diagnostic Inertia in Arterial Hypertension With a Gender Perspective in Primary Care

J. A. Quesada, A. López-Pineda, V. Gil-Guillén, 2022, Frontiers in Cardiovascular Medicine.

Saxagliptin and risk of heart failure hospitalization: Concern or miscalculation?

J. Franch-Nadal, D. Orozco-Beltrán, J. Navarro-Pérez, 2016, International journal of cardiology.

Correction: Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study

R. Cooper, S. Pita-Fernández, J. Redón, 2018, PloS one.

Impact of hypertension on mortality and cardiovascular disease burden in patients with cardiovascular risk factors from a general practice setting: the ESCARVAL-risk study

J. Redón, G. Sanz, J. Martin-Moreno, 2016, Journal of hypertension.

Patients’ and physicians’ preferences for type 2 diabetes mellitus treatments in Spain and Portugal: a discrete choice experiment

Marta Botella, Luis Lizán, Enric Esmatjes, 2015, Patient preference and adherence.

Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the valencian community of Spain

J. Díez-Domingo, J. Puig-Barberá, J. Navarro-Pérez, 2011, BMC infectious diseases.

Gender Differences in the Diagnosis of Dyslipidemia: ESCARVAL-GENERO

J. Martin-Moreno, J. A. Quesada, A. López-Pineda, 2021, International journal of environmental research and public health.

A new risk score to assess atrial fibrillation risk in hypertensive patients (ESCARVAL-RISK Project

L. García ortiz, J. A. Quesada, A. López-Pineda, 2020, Scientific Reports.

Mortality and cardiovascular disease burden of uncontrolled diabetes in a registry-based cohort: the ESCARVAL-risk study

J. Redón, J. Martin-Moreno, C. Sánchis, 2018, BMC Cardiovascular Disorders.

Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial

A. Borobia, B. Clotet, J. Prado, 2022, The Lancet Regional Health - Europe.

[Management of hyperglycaemia with non-insulin drugs in adult patients with type 2 diabetes].

D. Orozco-Beltrán, J. Navarro-Pérez, L. Ávila Lachica, 2019 .

Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes in primary care. The gap between guidelines and reality in Spain

M. Serrano-Ríos, V. Gil-Guillén, D. Orozco-Beltrán, 2007, International journal of clinical practice.

Is the Physician’s Behavior in Dyslipidemia Diagnosis in Accordance with Guidelines? Cross-Sectional Escarval Study

J. Redón, J. Martin-Moreno, V. Gil-Guillén, 2014, PloS one.

Inmates of the mid nineteenth-century Valencian asylum 'Hospital dels Ignoscents, Folls e Orats'. Is their illness diagnosable?

J. Navarro-Pérez, A. Beveridge, L. Livianos-Aldana, 2001, History of psychiatry.

Prevalence of inappropriate prescribing in complex chronic patients: Time trends in a health department of Valencia, Spain (2015-2019).

J. Navarro-Pérez, R. Usó-Talamantes, J. Trillo-Mata, 2022, Revista espanola de geriatria y gerontologia.

Barriers associated with poor control in Spanish diabetic patients. A consensus study

J. Franch-Nadal, M. Carratalá-Munuera, J. García-Soidán, 2013, International journal of clinical practice.

Rationale and methods of the cardiometabolic valencian study (escarval-risk) for validation of risk scales in mediterranean patients with hypertension, diabetes or dyslipidemia

Jose M Martin-Moreno, R. Cooper, S. Pita-Fernández, 2010, BMC public health.

Gender Inequalities in Diagnostic Inertia around the Three Most Prevalent Cardiovascular Risk Studies: Protocol for a Population-Based Cohort Study

J. Martin-Moreno, J. A. Quesada, A. López-Pineda, 2021, International journal of environmental research and public health.

The influence of hemoglobin A1c levels on cardiovascular events and all-cause mortality in people with diabetes over 70 years of age. A prospective study.

J. Redón, J. A. Quesada, A. López-Pineda, 2020, Primary care diabetes.

Home Blood Pressure Self-monitoring plus Self-titration of Antihypertensive Medication for Poorly Controlled Hypertension in Primary Care: the ADAMPA Randomized Clinical Trial

S. Peiró, I. Hurtado, V. Gosalbes, 2022, Journal of General Internal Medicine.

Effectiveness of a new health care organization model in primary care for chronic cardiovascular disease patients based on a multifactorial intervention: the PROPRESE randomized controlled trial

V. Gil-Guillén, D. Orozco-Beltrán, C. Carratalá-Munuera, 2013, BMC Health Services Research.

A new risk score to assess atrial fibrillation risk in hypertensive patients (ESCARVAL-RISK Project

L. García ortiz, J. A. Quesada, A. López-Pineda, 2020, Scientific Reports.

Clinical applicability and cost-effectiveness of DIABSCORE in screening for type 2 diabetes in primary care.

M. Carratalá-Munuera, I. Marcelino-Rodriguez, A. Cabrera de León, 2017, Diabetes research and clinical practice.

Cost of Type 2 Diabetes Patients with Chronic Kidney Disease Based on Real-World Data: An Observational Population-Based Study in Spain

J. Redón, J. Górriz, J. Navarro-Pérez, 2021, International journal of environmental research and public health.

[Analysis of potentially inappropriate prescriptions according to the START criteria in nursing homes].

J. Navarro-Pérez, J. Trillo-Mata, Isabel Díaz Planelles, 2021, Revista espanola de geriatria y gerontologia.

Indicadores de calidad en hiperplasia benigna de próstata. Un estudio cualitativo

S. Peiró, Jorge Navarro-Pérez, S. Peiró, 2013, Atencion primaria.